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Abstract	
The	 dinuclear	 copper(I)	 complexes	 [Cu2(1)(POP)2][PF6]2,	 [Cu2(2)(POP)2][PF6]2,	
[Cu2(1)(xantphos)2][PF6]2	and	[Cu2(2)(xantphos)2][PF6]2	containing	bridging	2,3,5,6-tetra(pyridin-
2-yl)pyrazine	 (1)	 or	 2,4,6-tri(pyridin-2-yl)-1,3,5-triazine	 (2)	 ligands	 and	 the	 P^P	 ligands	 bis(2-
(diphenylphosphino)phenyl)ether	 (POP)	 or	 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene	
(xantphos)	 are	 presented.	 The	 single	 crystal	 structures	 of	 [Cu2(1)(POP)2][PF6]2	 and	
[Cu2(2)(POP)2][PF6]2	confirm	that	both	1	and	2	act	as	bis(bidentate)	 ligands,	bridging	between	
two	copper(I)	centres;	 in	 [Cu2(1)(POP)2][PF6]2,	 two	pyridine	rings	are	non-coordinating,	and	 in	
[Cu2(2)(POP)2][PF6]2,	 there	 is	 one	 non-coordinating	 pyridine.	 In	 solution	 and	 on	 the	 NMR	
timescale	at	295	K,	the	four	pyridine	rings	in	coordinated	1	are	equivalent;	similarly,	the	three	
pyridine	donors	in	the	[Cu2(2)(P^P)2][PF6]2	complexes	are	equivalent.	The	dynamic	behaviour	of	
[Cu2(2)(POP)2][PF6]2	 and	 [Cu2(2)(xantphos)2][PF6]2	 are	 investigated	using	 variable	 temperature	
1H	NMR	spectroscopy.	The	photophysical	properties	of	the	complexes	are	discussed.		
____________________________________________	
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1.	Introduction	
	In	 contrast	 to	 conventional	 white-light	 sources,	 organic	 light-emitting	 diodes	 (OLEDs)	
and	light-emitting	electrochemical	cells	(LECs)	exhibit	beneficial	energy	savings	[1].	OLED	
technology	 is	 now	 well	 established,	 but	 the	 more	 recently	 developed	 LECs	 offer	 a	
number	 of	 advantages,	 including	 a	 simpler	 device	 architecture	 and	 assembly	 using	
solution	(not	vacuum)	processing.	The	active	layer	in	a	LEC	is	a	charged	material,	either	
an	 ionic	 transition	metal	 complex	 or	 a	 polymer	 [1].	 	 For	 the	 former,	 cyclometallated	
iridium(III)	complexes	are	the	most	popular	choices,	but	commercial	uptake	of	 iridium-
based	LECS	and	OLEDs	is	limited	by	the	low	abundance	of	iridium	in	the	Earth's	crust	[2]	
(≈3	×	10–6	ppm).	In	contrast,	copper	is	highly	abundant	and	cheap	[3],	and	over	the	last	
few	years,	the	potential	for	copper-containing	OLEDs	[4]	and	LECs	[5,6,7,8]	has	come	to	
the	 fore.	 Among	 the	 most	 promising	 emissive	 copper(I)	 complexes	 are	 heteroleptic	
[Cu(P^P)(N^N)]+	 species	 in	 which	 N^N	 is	 a	 diimine	 ligand	 and	 P^P	 is	 a	 sterically	
demanding	bis(phosphino)	chelate	such	as	bis(2-(diphenylphosphino)phenyl)ether	(POP)	
or	4,5-bis(diphenylphosphino)-9,9-dimethylxanthene	(xantphos)	[5,6,8–20].	A	number	of	
related	dicopper	complexes	have	also	been	reported	[21,22,23,24].	
	 Few	studies	have	focused	on	dinuclear	copper	complexes	for	application	 in	LECs.	Brüggler,	
De	Cola	and	coworkers	have	described	the	use	of	 rigid	 tetra(phosphino)	units	as	 the	bridging	
domains	 in	 dicopper(I)	 complexes	 [25],	 while	 the	 groups	 of	 Delavaux,	 Armaroli	 and	
Nierengarten	[26]	and	of	Weinhardt,	Baumann	and	Bräse	[27]	have	focused	on	the	use	of	P^N	
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bridging	domains.	As	an	extension	of	our	 studies	of	 [Cu(N^N)(POP)]+	 complexes	 in	which	 the	
N^N	domain	is	a	2,2':6',2''-terpyridine	(tpy)	ligand	[28],	we	now	report	a	series	of	four	dinuclear	
complexes	of	type	[Cu2(P^P)2(µ-L)]2+	in	which	P^P	is	either	POP	or	xantphos	and	µ-L	is	2,3,5,6-
tetra(pyridin-2-yl)pyrazine	(1)	or	2,4,6-tri(pyridin-2-yl)-1,3,5-triazine	(2)	(Scheme	1).	
 
	
Scheme	1.	The	structures	of	ligands	1	and	2,	and	a	comparison	of	their	metal-binding	domains	with	that	of	
2,2':6',2''-terpyridine	(tpy).	
	
2.	Experimental	
2.1		General	
1H,	 13C	and	31P	NMR	spectra	were	recorded	on	Bruker	Avance	 III-600,	 III-500	or	 III-400	
NMR	spectrometers.	1H	and	13C	NMR	chemical	shifts	were	referenced	to	residual	solvent	
peaks	 with	 respect	 to	 δ(TMS)	 =	 0	 ppm	 and	 31P	 NMR	 chemical	 shifts	 with	 respect	 to	
δ(85%	 aqueous	 H3PO4)	 =	 0	 ppm.	 Solution	 absorption	 and	 emission	 spectra	 were	
recorded	 with	 an	 Agilent	 8453	 spectrophotometer	 and	 Shimadzu	 RF-5301PC	
spectrofluorometer,	 respectively.	 Electrospray	 ionization	 (ESI)	 mass	 spectra	 were	
recorded	on	a	Bruker	esquire	3000plus	instrument.			
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2.2	 [Cu2(1)(POP)2][PF6]2			
A	colourless	solution	of	 [Cu(MeCN)4][PF6]	 (112	mg,	0.30	mmol)	and	POP	(162	mg,	0.30	
mmol)	in	CH2Cl2	(40	mL)	was	stirred	for	2	h.	Then	1	(58	mg,	0.15	mmol)	was	added	and	
the	 bright	 red	 solution	was	 stirred	 for	 another	 2	 h.	 The	 solution	was	 filtered	 and	 the	
filtrate	 evaporated	 to	 dryness.	 The	 red	 residue	 was	 redissolved	 in	 CH2Cl2	 (4	 mL),	
transferred	 to	 a	 tube	 and	 the	 solution	 layered	 with	 Et2O.	 This	 yielded	 red	 crystalline	
[Cu2(1)(POP)2][PF6]2	 (140	 mg,	 0.074	 mmol,	 49%).	 1H	 NMR	 (500	 MHz,	 CD2Cl2,	 295	 K)	
δ/ppm	8.24	(d,	J	=	4.7	Hz,	4H,	HB6),	7.28	(t,	J	=	7.9	Hz,	4H,	HB4),	7.24	(overlapping	m,	12H,	
HC5+D4),	7.13–7.06	(m,	20H,	HD3+B5),	7.09	(m,	4H,	HB5),	6.98	(t,	J	=	7.5	Hz,	4H,	HC4),	6.91	(m,	
4H,	HC6),	6.86	(m,	16H,	HD2),	6.69	(d,	J	=	7.9	Hz,	4H,	HB3),	6.66	(m,	4H,	HC3).	13C{1H}	NMR	
(126	MHz,	 CD2Cl2,	 295	 K)	δ/ppm	 157.6	 (CC1),	 153.1	 (CA2/B2),	 150.4	 (CA2/B2),	 150.2	 (CB6),	
138.3	 (CB4),	 134.9	 (CC3),	 132.8	 (CC5),	 131.0	 (CD4),	 130.5	 (CD1),	 129.5	 (CD3),	 127.1	 (CB3),	
126.5	 (CB5),	 125.9	 (CC4),	 120.4	 (CC6),	 CC2	 not	 resolved.	 31P{1H}	NMR	 (202	MHz,	 CD2Cl2).	
δ/ppm	 −11.8	 (br,	 FWHM	 =	 130	 Hz,	 POP),	 −144.7	 (septet,	 JPF	 =	 711	 Hz,	 [PF6]−).	 UV-Vis	
(CH2Cl2,	2.5	×	10–5	mol	dm–3):	λ	/	nm	(ε	/	dm3	mol–1	cm–1)	272sh	(50630),	346	(20450),	
485	 (4480).	ESI	MS:	m/z	989.7	 [Cu(1)(POP)]+	 (base	peak,	 calc.	989.2),	601.4	 [Cu(POP)]+	
(calc.	601.1).	Found	C	61.36,	H	4.22,	N	4.78;	C96H72Cu2F12N6O2P6	requires	C	61.25,	H	3.86,	
N	4.46%.	
2.3		 [Cu2(2)(POP)2][PF6]2		
A	 solution	 of	 [Cu(MeCN)4][PF6]	 (93	mg,	 0.25	mmol)	 and	 POP	 (134	mg,	 0.25	mmol)	 in	
CH2Cl2	(40	mL)	was	stirred	for	2	h.	Then	2	(39	mg,	0.125	mmol)	was	added	and	the	dark	
red	solution	was	stirred	for	2	h.	The	solution	was	filtered	and	the	filtrate	evaporated	to	
dryness.	 [Cu2(2)(POP)2][PF6]2	was	 isolated	as	a	dark	 red	powder	 (185	mg,	0.102	mmol,	
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82%).	 1H	 NMR	 (500	 MHz,	 CD2Cl2,	 295	 K)	δ/ppm	 8.19	 (broad,	 see	 text),	 7.33	 (m,	 7H,	
HC5+B5),	7.25	(t,	J	=	7.5	H,	8H,	HD4),	7.11	(t,	J	=	7.6	Hz,	4H,	HC4),	7.06-6.94	(broad	m,	20H,	
HD3+C6),	 6.89	 (m,	 4H,	 HC3),	 6.78	 (m,	 16H,	 HD2).	 13C{1H}	 NMR	 (126	MHz,	 CD2Cl2)	 δ/ppm	
158.1	(t,	J	=	6.0	Hz,	CC1),	134.7	(CC3),	133.5	(br,	CD2),	133.1	(CC5),	130.9	(CD4),	130.6	(CD1),	
130.1	(CB5),	129.4	(t,	J	=	5.1	Hz,	CD3),	126.1	(CC4),	124.5	(t,	J	=	15.4	Hz,	CC2),	120.5	(CC6),	
CA2,B2,B3,B4	not	resolved.	31P{1H}	NMR	(202	MHz,	CD2Cl2).	δ/ppm	−10.9	(br,	FWHM	=	130	
Hz,	POP),	−144.4	(septet,	JPF	=	711	Hz,	[PF6]−).	UV-Vis	(CH2Cl2,	2.5	×	10–5	mol	dm–3):	λ	/	
nm	(ε	/	dm3	mol–1	cm–1)	277	(55440),	489	(6340).	ESI	MS:	m/z	913.6		[Cu(2)(POP)]+	(base	
peak,	 calc.	 913.20),	 601.4	 	 [Cu(POP)]+	 (calc.	 601.09).	 Found	 C	 59.25,	 H	 4.22,	 N	 4.77;	
C90H68Cu2F12N6O2P6	requires	C	59.84,	H	3.79,	N	4.65%.	
2.4	 [Cu2(1)(xantphos)2][PF6]2		
A	solution	of	[Cu(MeCN)4][PF6]	(112	mg,	0.30	mmol)	and	xantphos	(174	mg,	0.30	mmol)	
in	CH2Cl2	(40	mL)	was	stirred	for	2	h,	after	which	1	(58	mg,	0.15	mmol)	was	added.	The	
dark	red	solution	was	stirred	for	2	h,	and	then	filtered.	After	removal	of	solvent	from	the	
filtrate,	 [Cu2(1)(xantphos)2][PF6]	 was	 isolated	 as	 a	 red	 powder	 (285	 mg,	 0.15	 mmol,	
97%).	1H	NMR	(500	MHz,	CD2Cl2,	295	K)	δ/ppm	7.93	(broad,	see	text),	7.63	(dd,	J	=	7.8,	
1.2	Hz,	4H,	HC5),	7.26	(overlapping	m,	12H,	HD4+C4),	7.17	(t,	J	=	7.5	Hz,	16H,	HD3),	7.09	(m,	
16H,	HD2),	6.97	(broad,	see	text),	6.84	(m,	4H,	HC3),	6.72	(broad,	see	text),	1.61	(s,	12H,	
Hxantphos-Me).	 	 13C{1H}	 NMR	 (126	 MHz,	 CD2Cl2)	 δ/ppm	 154.6	 (CC1),	 153.2	 (CA2/B2),	 152.2	
(CA2/B2),	150.1	(CB6),	137.4	(br,	CB4),	134.2	(CC6),	133.3	(t,	JPC	=	8.2	Hz,	CD2),	131.2	(m,	CD1),	
130.9	 (CD4),	129.5	 (t,	 JPC	=	4.8	Hz,	CD3),	128.1	 (CC5),	126.4	 (br,	CB3/B5),	126.2	 (br,	CB3/B5),	
125.6	(CC4),	119.5	(m,	CC2),	36.2	(Cxantphos-bridge),	28.2	(Cxantphos-Me).	31P{1H}	NMR	(202	MHz,	
CD2Cl2)	δ/ppm	−13.8	(FWHM	=	45	Hz,	xantphos),	−144.6	(septet,	JPF	=	711	Hz,	[PF6]−).	UV-
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Vis	(CH2Cl2,	2.5	×	10–5	mol	dm–3):	λ	/	nm	(ε	/	dm3	mol–1	cm–1)	275	(58180),	333	(18460),	
485	(5390).	ESI	MS:	m/z	1029.7	[Cu(1)(xantphos)]+	(calc.	1029.3),	641.4	[Cu(xantphos)]+	
(calc.	 641.1),	 611.4	 [(xantphos)O2+H]+	 (calc.	 611.2).	 Found	 C	 60.22,	 H	 4.11,	 N	 4.28;	
C102H80Cu2F12N6O2P6.H2O	requires	C	61.85,	H	4.17,	N	4.24%.	
2.4	 [Cu2(2)(xantphos)2][PF6]2		
A	CH2Cl2	(40	mL)	solution	of	[Cu(MeCN)4][PF6]	(112	mg,	0.30	mmol)	and	xantphos	(174	
mg,	 0.30	mmol)	was	 stirred	 for	 2	 h.	 Then	2	 (47	mg,	 0.15	mmol)	was	 added.	 The	 red	
solution	was	 stirred	 for	 2	 h,	 then	was	 filtered	 and	 the	 filtrate	 evaporated	 to	 dryness.	
[Cu2(2)(xantphos)2][PF6]2	 was	 isolated	 as	 a	 dark	 red	 powder	 (265	 mg,	 0.140	 mmol,	
93.6%).	1H	NMR	(500	MHz,	CD2Cl2,	295	K)	δ/ppm	8.90	(br),	8.83	(br),	8.29	(br),	8.25	(br),	
7.70	(d,	J	=	7.7	Hz),	7.65	(dd,	J	=	7.8,	1.4	Hz),	7.41	(br),	7.33–7.21	(br),	7.21	(t,	J	=	7.7	Hz),	
7.05	(br),	6.99	(br),	6.87	(br),	6.09	(br),	5.82	(br).	13C{1H}	NMR	(126	MHz,	CD2Cl2,	295	K,	
see	text)	δ/ppm	155.1	(t,	JPC	=	6.4	Hz,	CC1),	150.0,	140.6,	134.4	(CC6),	133.2	(t,	JPC	=	7.6	
Hz),	131.0,	129.8,	129.3,	128.5	(CC5),	125.8	(CC4),	119.5	(m,	CC2),	36.4	(Cxantphos-bridge),	31.1	
(Cxantphos-Me),	26.2	(Cxantphos-Me),	see	text	discussion.	31P{1H}	NMR	(202	MHz,	CD2Cl2)	δ/ppm	
−12.2	 (br,	 FWHM	 =	 100	 Hz,	 xantphos),	 −144.4	 (septet,	 JPF	 =	 711	 Hz,	 [PF6]−).	 UV-Vis	
(CH2Cl2,	2.5	×	10–5	mol	dm–3):	λ/nm	(ε	/	dm3	mol–1	cm–1)	279	(71920),	486	(6200).	ESI	MS:	
m/z	 953.6	 [Cu(1)(xantphos)]+	 (calc.	 953.2),	 611.4	 [(xantphos)O2+H]+	 (calculated	 611.2).	
Found	C	61.02,	H	4.42,	N	4.77;	C96H76Cu2F12N6O2P6	requires	C	61.12,	H	4.06,	N	4.45%.	
	
2.5	Crystallography	
Data	 were	 collected	 on	 a	 Bruker	 Kappa	 Apex2	 diffractometer	 with	 data	 reduction,	
solution	 and	 refinement	 using	APEX	 [29]	 and	CRYSTALS	 [30].	 The	 program	Mercury	 v.	
	 7	
3.5.1	 [31,32]	 was	 used	 to	 draw	 ORTEP	 diagrams	 and	 for	 structural	 analysis.	 It	 was	
necessary	to	use	SQUEEZE	[33]	to	treat	the	solvent	region	of	the	complex	with	ligand	2,	
and	the	electron	density	removed	equated	to	1.8	molecules	of	CH2Cl2	per	two	Cu	atoms.	
	
2.6	 [Cu2(1)(POP)2][PF6]2.4H2O		
C96H80Cu2F12N6O6P6,	M	=	1950.20,	red	block,	triclinic,	space	group	P−1,	a	=	11.4824(4),	b	
=	 12.9997(5),	 c	 =	 17.5773(7)	Å,		 α		=	 105.577(2),	β	 =	 90.915(3),	 γ	 =	 90.160(2)o,	 U	 =	
2526.97(17)	Å3,	Z	=	1,	Dc	=	1.281	Mg	m–3,	µ(Cu-Kα)	=	2.047	mm−1,	T	=	123	K.	Total	37988	
reflections,	9357	unique,	Rint	=	0.061.	Refinement	of	7405	reflections	(571	parameters)	
with	I	>2σ	(I)	converged	at	final	R1	=	0.0914	(R1	all	data	=	0.1094),	wR2	=	0.2375	(wR2	all	
data	=	0.2493),	gof	=	0.9582.		
	
2.7	 [Cu2(2)(POP)2][PF6]2.1.8CH2Cl2		
C91.8H71.6Cu2F12N6O2P6Cl3.6,	M	=	1958.11,	red	block,	triclinic,	space	group	P−1,	a	=	13.5571(8),	b	=	
17.2958(10),	c	=	20.1831(11)	Å,	α  =	103.019(3),  β	=	90.392(3),	γ	=	104.416(3)o,	U	=	4455.8(2)	
Å3,	Z	=	2,	Dc	=	1.46	Mg	m–3,	µ(Cu-Kα)	=	3.232	mm−1,	T	=	123	K.	Total	47969	reflections,	15698	
unique,	 Rint	 =	 0.039.	 Refinement	 of	 12059	 reflections	 (1099	 parameters)	 with	 I	 >2σ (I)	
converged	at	final	R1	=	0.0470	(R1	all	data	=	0.0620),	wR2	=	0.1207	(wR2	all	data	=	0.1372),	gof	=	
0.91890.		
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Scheme	2.	Structures	of	complexes	with	atom	labelling	for	NMR	spectroscopic	characterization.	
	
3	 Results	and	discussion	
3.1	 Synthesis	and	structural	characterization	of	complexes	
The	copper	complexes	(Scheme	2)	were	prepared	by	first	[5]	combining	[Cu(MeCN)4][PF6]	
with	POP	or	xantphos,	followed	by	the	addition	of	1	or	2.	The	products	were	obtained	as	
red	 solids	 in	 yields	 ranging	 from	 49	 to	 97%.	 The	 highest	 mass	 peak	 envelope	 in	 the	
electrospray	 mass	 spectrum	 of	 each	 complex	 corresponded	 to	 [Cu(P^P)(1)]+	 or	
[Cu(P^P)(2)]+;	 no	 molecular	 ion	 corresponding	 to	 a	 dicopper	 species	 was	 detected.	
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Satisfactory	 elemental	 analyses	 were	 obtained	 for	 the	 complexes,	 but	 to	 confirm	 the	
dinuclear	nature	of	the	complexes,	single	crystal	structure	data	were	necessary. 
	 The	crystal	structures	of	 [Cu2(1)(POP)2][PF6]2.2H2O	and	[Cu2(2)(POP)2][PF6]2.1.8CH2Cl2	
were	determined.	For	the	latter,	the	program	SQUEEZE	[33]	was	used	to	treat	the	solvent	
region,	and	the	electron	density	removed	equated	to	1.8	molecules	of	CH2Cl2	per	two	Cu	
atoms.	 Both	 compounds	 crystallize	 in	 the	 centrosymmetric	 space	 group	 P–1,	 and	 in	
[Cu2(1)(POP)2][PF6]2.4H2O,	the	[Cu2(1)(POP)2]2+	cation	resides	on	an	inversion	centre	(Fig.	
1).	 Ligand	1	 binds	 in	 a	bis(bidentate)	mode,	with	Cu–N	bonds	 lengths	of	 2.146(4)	 and	
2.075(4)	Å	(see	caption	to	Fig.	1)	and	a	long	non-bonded	separation	for	the	third	donor	
(Cu1...N3	=	3.165(5)	Å).	Atom	Cu1	is	in	a	distorted	tetrahedral	environment	with	angles	
ranging	from	79.47(15)	to	134.21(11)o	(see	Fig.	1	caption).	The	Cu–P	bond	distances	and	
P1–Cu1–P2	 angle	 are	 as	 expected	 (see	 caption	 to	 Fig.	 1).	 The	 coordinated	
pyridylpyrazine	unit	is	significantly	twisted	(angle	between	the	ring	planes	=	34.9o),	and	
for	each	ring,	the	Cu–N	vector	deviates	substantially	from	the	plane	of	the	heterocycle.	
We	 [6]	 and	 others	 [34]	 have	 previously	 commented	 upon	 this	 phenomenon	 in	
[M(POP)(N^N)]+	complexes	with	M	=	Cu	or	Ag.	The	ring	containing	N3	 is	 twisted	64.2o	
with	respect	to	the	plane	of	the	coordinated	pyridine	ring	containing	N2,	and	engages	in	
a	 face-to-face	 π-stacking	 interaction	 with	 the	 pyrazine	 ring.	 A	 second	 interaction	
generated	 by	 inversion	 leads	 to	 the	 triple-decker	 stack	 shown	 in	 Fig.	 2;	 this	 is	
characterized	by	centroid...centroid	and	centroid...plane	separations	of	3.77	and	3.65	Å,	
respectively,	and	an	interplane	angle	of	11.4o	(which	is	non-optimal	for	the	π-contact).	
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Fig.	1.	Structure	of	the	[Cu2(1)(POP)2]
2+	cation	in	[Cu2(1)(POP)2][PF6]2
.4H2O;	H	atoms	are	omitted	for	clarity,	
and	only	the	 ipso-C	atoms	of	the	phenyl	rings	are	shown.	Ellipsoids	are	plotted	at	40%	probability	 level.	
Symmetry	 code	 i	 =	 –x,	 2–y,	 –z.	 Selected	 bond	 parameters:	 Cu1–P1	 =	 2.2693(14),	 Cu1–P2	 =	 2.2328(13),	
Cu1–N1	=	2.146(4),	Cu1–N2	=	2.075(4)	Å;	P1–Cu1–P2	=	117.05(5),	P1–Cu1–N1	=	106.65(12),	P2–Cu1–N1	=	
104.32(11),	P1–Cu1–N2	=	104.67(11),	P2–Cu1–N2	=	134.21(11),	N1–Cu1–N2	=	79.47(15)o.	Colour	online.	
	
Fig.	2.	Centrosymmetric	triple	decker	π-stack	in	the	[Cu2(1)(POP)2]2+	cation.	Colour	online.			
	
	 Fig.	 3	 shows	 the	 structure	 of	 the	 [Cu2(2)(POP)2]2+	 cation	 in	
[Cu2(2)(POP)2][PF6]2.1.8CH2Cl2.	The	bis(bidentate)	coordination	mode	of	 ligand	2	 leaves	
atom	N6	of	the	triazine	ring	and	one	pyridine	ring	uncoordinated.	Each	Cu	atom	has	a	
distorted	tetrahedral	geometry	with	a	range	of	angles	of	79.32(10)	to	132.90(7)o	for	Cu1,	
and	79.17(10)	 to	128.80(8)o	 for	Cu2;	bond	distances	are	unexceptional	 (see	caption	 to	
	 11	
Fig.	 2).	Although	 the	O-donors	 in	 the	POP	 ligand	are	not	bound	 to	 copper,	one	Cu...O	
distance	 is	 rather	 short	 (Cu2...O2	 =	 2.825(2)	 Å,	 compared	 to	 Cu1...O1	 =	 3.034(2)	 Å).	
These	values	straddle	the	one	in	the	[Cu2(1)(POP)2]2+	cation	(Cu1...O1	=	2.966(4)	Å.	
	
Fig.	3.	Structure	of	the	[Cu2(2)(POP)2]2+	cation	in	[Cu2(2)(POP)2][PF6]2.1.8CH2Cl2;	for	clarity,	H	atoms	are	
omitted	and	only	the	ipso-C	atoms	of	the	phenyl	rings	are	shown.	Ellipsoids	are	plotted	at	40%	
probability	level.	Selected	bond	parameters:	Cu1–P1	=	2.2563(9),	Cu1–P2	=	2.2677(9),	Cu1–N4	=	
2.115(2),	Cu1–N5	=	2.115(3),	Cu2–P3	=	2.2302(9),	Cu2–P4	=	2.2381(9),	Cu2–N1	=	2.116(3),	Cu2–N2	=	
2.114(3)	Å;	P1–Cu1–P2	=	115.07(3),	P1–Cu1–N4	=	132.90(7),	P2–Cu1–N4	=	106.87(7),	P1–Cu1–N5	=	
104.88(7),	P2–Cu1–N5	=	109.32(8),	N4–Cu1–N5	=	79.32(10),	P3–Cu2–	P4	=	118.57(4),	P3–Cu2–N1	=	
113.27(8),	P4–Cu2–N1	=	102.17(8),	P3–Cu2–N2	=	106.65(8),	P4–Cu2–N2	=	128.80(8),	N1–Cu2–N2	=	
79.17(10)o.	Colour	online.			
	
The	non-coordinated	pyridyl	ring	in	the	[Cu2(2)(POP)2]2+	cation	is	hosted	within	a	cavity	
between	four	phenyl	rings,	one	from	each	PPh2	unit	(Fig.	4a);	however,	only	one	edge-
to-face	π-contact	is	efficient	(CH...centroid	=	2.55	Å).	Despite	the	multiple	arene	rings	in	
the	[Cu2(2)(POP)2]2+	cation,	only	two	face-to-face	π-stacking	interactions	occur	(Fig.	4b),	
and	 neither	 has	 optimal	 metric	 characteristics.	 The	 first	 π-contact	 is	 within	 one	 POP	
ligand	 (angle	 between	 ring	 planes	 =	 14.3o,	 centroid...ring	 plane	 =	 3.62	 Å,	 distance	
between	ring	centroids	=	3.74	Å)	and	the	second	 is	between	the	phenyl	 ring	with	C85	
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and	 the	 pyridine	 ring	 of	 2	 containing	 N1	 (angle	 between	 ring	 planes	 =	 21.6o,	
centroid...ring	plane	=	3.41	Å,	centroid...centroid	separation	=	3.77	Å).	
		 	
	 	 	 	 (a)	 	 	 													(b)	
Fig.	4.	The	[Cu2(2)(POP)2]2+	cation	showing	(a)	accommodation	of	the	non-coordinated	pyridyl	ring	
within	a	cavity	of	four	phenyl	rings	of	PPh2	units,	and	(b)	face-to-face	π-stacking	interactions	within	one	
POP	ligand	(left)	and	between	POP	and	ligand	2	(right).	Colour	online.			
	
Preliminary	single	crystal	data	for	[Cu2(1)(xantphos)2][PF6]2	were	obtained	and	confirmed	that,	like	
[Cu2(1)(POP)2][PF6]2.4H2O,	the	complex	crystallizes	in	the	space	group	P–1	with	
centrosymmetric	dinuclear		[Cu2(1)(xantphos)2]2+	cations	in	which	ligand	1	is	bidentate.		
	
Solution	NMR	spectroscopic	properties	
Solution	 1H	 and	 13C	 NMR	 spectra	 of	 [Cu2(1)(POP)2][PF6]2,	 [Cu2(2)(POP)2][PF6]2,	
[Cu2(1)(xantphos)2][PF6]2	 and	 [Cu2(2)(xantphos)2][PF6]2	 were	 recorded	 in	 CD2Cl2	 and	
were	assigned	using	COSY,	NOESY,	HMQC	and	HMBC	methods.	 Ligand	1	 presents	 two	
tpy	metal-binding	domains	in	a	'back-to-back'	arrangement.	The	solid-state	structure	of	
[Cu2(1)(POP)2][PF6]2	 (Fig.	 1)	 shows	 1	 acting	 as	 a	 bis(bidentate)	 ligand,	 with	 two	
uncoordinated	pyridine	 rings.	However,	 in	 solution	at	295	K,	 the	 1H	NMR	spectrum	of	
[Cu2(1)(POP)2][PF6]2	 (Fig.	5a)	exhibits	only	one	set	of	 signals	 for	 the	 four	pyridine	 rings	
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(ring	B,	Scheme	2).	This	is	consistent	with	either	1	functioning	as	two	tpy	domains,	or	a	
low	energy	dynamic	process	 interconverting	bpy	domains	as	 shown	 in	 Scheme	3.	 This	
mimics	what	is	observed	in	[Cu(POP)(tpy)][PF6]	and	related	complexes	[28,35].	The	close	
proximity	of	the	two	metal-binding	sites	results	in	the	signal	for	HB3	(which	resides	above	
the	ring	current	of	a	pyridine	ring	of	the	adjacent	tpy	domain)	appearing	at	relatively	low	
frequency	(δ	6.69	ppm	compared	to	δ	7.80	ppm	in	[Cu(POP)(tpy)][PF6]	[28]).	A	less	drastic	
shift	is	seen	for	the	signal	for	HB4	(δ	7.28	ppm	in	[Cu2(1)(POP)2][PF6]2	versus	δ 7.62	ppm	
in	[Cu(POP)(tpy)][PF6]	[28]).	
	
Scheme	3.	Interconversion	of	two	bpy	metal-binding	domains	renders	rings	B	and	B'	equivalent.	
	 	
Fig.	 5.	 Aromatic	 region	 of	 the	 500	 MHz	 1H	 NMR	 spectra	 of	 a	 CD2Cl2	 solution	 at	 295	 K	 of	 (a)	
[Cu2(1)(POP)2][PF6]2	and	(b)	[Cu2(1)(xantphos)2][PF6]2.	Chemical	shifts	in	δ/ppm.	
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	 Fig.	 5	 shows	 a	 comparison	 of	 the	 aromatic	 region	 of	 the	 1H	 NMR	 spectra	 of	
[Cu2(1)(POP)2][PF6]2	and	[Cu2(1)(xantphos)2][PF6]2.	The	loss	of	the	signal	for	HC6	on	going	
from	Fig.	5a	to	5b	is	consistent	with	the	introduction	of	the	bridging	CMe2	in	xantphos.	A	
significant	 change	 is	 the	broadening	and	 shifting	 to	 lower	 frequency	of	 the	 signals	 for	
the	pyridine	 ring	protons.	The	signals	 for	HB3,	HB4,	HB5	and	HB6	 (Fig.	5b)	were	assigned	
combining	the	characteristic	13C	chemical	shifts	of	CB6	and	CB4	(see	the	HMQC	spectrum	
in	 Fig.	 6)	 and	 the	 appearance	 of	 an	 HB3/HB4	 crosspeak	 in	 the	 COSY	 spectrum.	 The	
appearance	of	the	pyridine	proton	signals	at	295	K	(Fig.	5b)	is	most	likely	associated	with	
dynamic	processes	involving	(i)	the	interconversion	shown	in	Scheme	3,	and	(ii)	inversion	
of	 the	 bowl-like	 xanthene	 unit.	 We	 have	 previously	 described	 the	 interconversion	 of	
conformers	 via	 xanthene	 inversion	 in	 the	 related	 complex	 [Cu(Phbpy)(xantphos)][PF6]	
(Phbpy	=	6-phenyl-2,2'-bipyridine)	[36]	and	we	return	to	this	below.	
	
	
Fig.	6.	Part	of	the	HMQC	spectrum	(applied	magnetic	field	=	11.75	T)	of	[Cu2(1)(xantphos)2][PF6]2	(in	CD2Cl2)	
showing	pyridine	ring	1H	and	13C	NMR	signal	assignments.	Chemical	shifts	in	δ/ppm.	
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At	 room	 temperature,	 the	 solution	 1H	 NMR	 spectrum	 of	 [Cu2(2)(POP)2][PF6]2	 exhibits	
signals	arising	from	the	POP	ligand	and	a	broad	signal	at	δ	8.19	ppm	(top	spectrum	in	Fig.	
7).	Use	of	COSY,	HMQC	and	HMBC	allowed	the	POP	ligand	resonances	to	be	assigned.	In	
the	 HMQC	 spectrum	 (Fig.	 8),	 the	 broad	 1H	 NMR	 signal	 at	 δ	 8.19	 ppm	 showed	 a	
correlation	to	a	13C	resonance	at	δ	150.1	ppm	(unresolved	in	the	1D	spectrum),	allowing	
this	to	be	assigned	to	HB6;	this	is	analogous	to	the	crosspeak	assignment	shown	in	Fig.	5	
for	 [Cu2(1)(POP)2][PF6]2.	 In	 addition,	 the	 1H	 NMR	 signal	 at	 δ	 7.32	 ppm	 gave	 two	
correlation	peaks	 to	δ13C	 130.1	 ppm	 (unresolved	 in	 the	 1D	 spectrum,	 Fig.	 8)	 and	δ13C	
133.1	ppm	assigned	to	CB5	and	CC5,	respectively.		Upon	cooling	(Fig.	7),	all	signals	initially	
collapse.	 At	 215	 K,	 ligand	 2	 exhibits	 two	 pyridine	 environments	 in	 a	 ratio	 of	 2	 :	 1,	
consistent	with	 two	 chelating	 bpy	domains	 and	one	non-coordinated	pyridine	 ring,	 as	
seen	 in	 the	 solid-state	 structure	 (Fig.	 3).	 The	 C	 ring	 of	 the	 POP	 ligand	 retains	 one	
environment	 between	 295	 and	 215	 K,	 while	 the	 phenyl	 rings	 D	 separate	 into	 two	
environments	 (Fig.	 7).	 The	 observations	 can	 be	 rationalized	 in	 terms	 of	 two	 dynamic	
processes.	Cooling	the	sample	first	freezes	out	a	process	that	renders	the	three	pyridine	
rings	equivalent,	a	process	related	to	that	 in	Scheme	3	but	 involving	only	one	pendant	
pyridine	 ring.	 As	 the	 pyridine	 rings	 in	 ligand	 2	 separate	 into	 the	 chelating	 and	 non-
coordinated	 sets	 (Fig.	 9),	 the	 phenyl	 rings	 of	 each	 PPh2	 unit	 are	 rendered	 non-
equivalent.	 One	 set	 (coloured	 pale	 blue	 in	 Fig.	 9)	 faces	 the	 non-coordinated	 pyridine	
ring,	 while	 the	 second	 set	 (green	 in	 Fig.	 9)	 is	 directed	 towards	 the	 other	 side	 of	 the	
complex.	 The	 lowest	 energy	 dynamic	 process	 is	 the	 flipping	 of	 the	 diphenyl	 ether	
backbone	of	the	POP	ligand;	with	this	motion	persisting	at	215	K,	the	four	green	Ph	units	
are	made	equivalent,	as	are	the	four	pale	blue	Ph	rings.			
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Fig.	7.	Variable	temperature	500	MHz	1H	NMR	spectra	of	a	CD2Cl2	solution	of	[Cu2(2)(POP)2][PF6]2.	Chemical	shifts	
in	δ/ppm.	See	Scheme	2	for	atom	labelling.	
	
Fig.	8.	Part	of	the	HMQC	spectrum	(applied	magnetic	field	=	11.75	T)	of	[Cu2(2)(POP)2][PF6]2	(in	CD2Cl2	at	295	K)	
showing	pyridine	ring	B6	and	B5	signal	assignments.	The	13C	resonances	are	not	resolved	at	295	K	in	the	1D	
spectrum.	Chemical	shifts	in	δ/ppm.	
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Fig.	9.	Structure	of	the	[Cu2(2)(POP)2]
2+	cation	(from	the	crystallographically	determined	structure)	with	phenyl	
rings	coloured	to	show	the	two	sets	observed	in	solution	at	215	K.	Colour	online.			
	 The	 room	 temperature	 solution	 1H	 NMR	 spectrum	 of	 [Cu2(2)(xantphos)2][PF6]2	
consists	 largely	of	broad	signals	with	the	exception	of	sharp	signals	at	δ	7.65	and	7.21	
ppm	(a	doublet	of	doublets	and	a	triplet,	respectively).	In	addition	to	a	septet	assigned	
to	the	[PF6]–	ion,	the	31P{1H	}	NMR	spectrum	exhibits	a	broadened	singlet	at	δ	–12.2	ppm	
consistent	with	one	environment	on	the	NMR	timescale	for	the	four	PPh2	groups.	Across	
a	series	of	related	complexes,	13C	NMR	chemical	shifts	tend	to	be	diagnostic,	and	Fig.	10	
compares	 parts	 of	 the	 13C	 NMR	 spectra	 of	 [Cu2(1)(xantphos)2][PF6]2	 and	
[Cu2(2)(xantphos)2][PF6]2.	Some	similarities	are	clear,	and	combined	with	analysis	of	the	
HMQC	spectrum	(Fig.	11),	it	is	possible	to	assign	the	signals	for	xantphos	ring	C	protons	
and	 13C	 nuclei.	 Inspection	 of	 Fig.	 10	 and	 11	 indicates	 that	 there	 are	 two	 phenyl	
environments,	 analogous	 to	 the	 situation	 in	 [Cu(Phbpy)(xantphos)][PF6]	 at	 295	 K	 [36].	
Variable	 temperature	1H	NMR	spectra	were	recorded	between	295	and	215	K	and	the	
aromatic	 regions	 of	 the	 spectra	 shown	 in	 Fig.	 12	 reveal	 that	 at	 least	 two	 dynamic	
processes	are	operative.	The	behaviour	of	the	methyl	signals	for	the	xantphos	CMe2	unit	
is	 also	 consistent	 with	 this.	 The	 dynamic	 behaviour	 observed	 for	 [Cu2(2)(POP)2][PF6]2	
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(Fig.	7)	coupled	with	the	inversion	of	the	two	xanthene	units	in	[Cu2(2)(xantphos)2][PF6]2	
render	the	system	complex	and	we	have	not	investigated	the	processes	in	greater	detail.		
	
Fig.	10.	Comparison	of	parts	of	the	126	MHz	13C	NMR	spectra	of	CD2Cl2	solutions	of	(a)	[Cu2(1)(xantphos)2][PF6]2	
and	(b)	[Cu2(2)(xantphos)2][PF6]2.	Chemical	shifts	in	δ /	ppm.	See	Scheme	2	for	atom	labelling.	
	
Fig.	11.	Part	of	the	HMQC	spectrum	(applied	magnetic	field	=	11.75	T)	of	[Cu2(2)(xantphos)2][PF6]2.	Chemical	shifts	
in	δ /	ppm.	See	Scheme	2	for	atom	labelling.	
	 19	
	
Fig.	12.	Aromatic	region	of	the	variable	temperature	500	MHz	1H	NMR	spectra	of	a	CD2Cl2	solution	of	
[Cu2(2)(xantphos)2][PF6]2.	Chemical	shifts	in	d	/	ppm.	*	=	residual	CHDCl2.	
	
	
Photophysical	properties	
The	 solution	absorption	 spectra	of	 the	 [Cu2(N^N)(P^P)2][PF6]2	 complexes	are	 shown	 in	
Fig.	 13.	 The	 high-energy	 bands	 are	 assigned	 to	 spin-allowed,	 ligand-based	 π*←π	 and	
π*←n	transitions,	and	the	profile	of	the	spectrum	below	380	nm	depends	upon	the	N-
heterocycle	 ligand	present	 in	 the	complex.	Each	complex	exhibits	a	broad	band	 in	 the	
visible	region,	with	λmax	=	485	nm	for	[Cu2(1)(POP)2][PF6]2	and	[Cu2(1)(xantphos)2][PF6]2,	
and	487	or	489	nm	for	the	complexes	containing	ligand	2.	This	band	is	assigned	to	metal-
to-ligand	 charge	 transfer	 (MLCT)	 and	 is	 red-shifted	 by	 up	 to	 100	 nm	with	 respect	 to	
related	mononuclear	[Cu(N^N)(P^P)][PF6]	complexes	[5,6,10,14,36,37].		
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Fig.	13.	Absorption	spectra	of	[Cu2(N^N)(P^P)2][PF6]2	with	N^N	=	1	or	2,	and	P^P	=	POP	or	xantphos	
(CH2Cl2,	2.5	x	10–5	mol	dm–3).	Colour	online.	
	 	
At	room	temperature	in	both	solution	and	the	solid	state,	the	complexes	are	very	weakly	
emissive	 when	 excited	 at	 wavelengths	 between	 270	 and	 490	 nm,	 and	 we	 have	 not,	
therefore,	investigated	the	emission	behaviour	in	detail.		
	
	
4.	Conclusions	
We	 have	 prepared	 and	 characterized	 the	 dinuclear	 copper(I)	 complexes	 [Cu2(1)(POP)2][PF6]2,	
[Cu2(2)(POP)2][PF6]2,	 [Cu2(1)(xantphos)2][PF6]2	 and	 [Cu2(2)(xantphos)2][PF6]2.	 The	 bridging	
nature	of	1	and	2	has	been	confirmed	in	the	single	crystal	structures	of	[Cu2(1)(POP)2][PF6]2	and	
[Cu2(2)(POP)2][PF6]2.	In	the	solid	state,	1	and	2	both	function	as	bis(bidentate)	ligands	with	two	
and	 one	 non-coordinating	 pyridine	 ring,	 respectively.	 In	 solution	 at	 room	 temperature,	 each	
complex	 exhibits	 a	 single	 pyridine	 environment,	 consistent	with	dynamic	 behaviour.	 This	 has	
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been	 investigated	 in	 [Cu2(2)(POP)2][PF6]2	 and	 [Cu2(2)(xantphos)2][PF6]2	 by	 using	 variable	
temperature	 1H	 NMR	 spectroscopy.	 Cooling	 a	 solution	 of	 [Cu2(2)(POP)2][PF6]2	 freezes	 out	 a	
process	that	renders	the	three	pyridine	rings	equivalent;	the	lowest	energy	dynamic	process	is	
the	 flipping	 of	 the	 diphenyl	 ether	 backbone	 of	 the	 POP	 ligand.	 The	 dynamic	 processes	 in	
[Cu2(2)(xantphos)2][PF6]2	are	more	complex,	with	the	inversion	of	the	two	xanthene	units	being	
coupled	to	the	processes	observed	in	[Cu2(2)(POP)2][PF6]2.	The	photophysical	properties	of	the	
complexes	have	been	investigated,	but	in	contrast	to	the	emissive	properties	exhibited	by	many	
[Cu(N^N)(P^P)][PF6]	 complexes,	 [Cu2(1)(POP)2][PF6]2,	 [Cu2(1)(xantphos)2][PF6]2,	
[Cu2(2)(POP)2][PF6]2	and	[Cu2(2)(xantphos)2][PF6]2	are	only	weakly	emissive	in	solution	or	in	the	
solid	at	room	temperature.	
	
Appendix	1	 Supplementary	data						
Crystallographic	 data	 for	 all	 the	 complexes	 have	 been	 deposited	 with	 the	 CCDC	 (Cambridge	
Crystallographic	Data	Centre,	12	Union	Road,	Cambridge	CB2	1EZ,	UK;	fax	+44	1223	336	033;	e-
mail:	deposit@ccdc.cam.ac.uk	or	www:	http://www.ccdc.cam.ac.uk)	and	may	be	obtained	free	
of	charge	on	quoting	the	deposition	numbers	CCDC	1421984	and	1421985.	
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